US drugmaker Eli Lilly says it will sell single-use vials of its weight-loss drug Zepbound, amid skyrocketing demand among Americans for anti-obesity medications. Under the new pricing plan, a month's supply of the lowest dose, 2.5 milligrams, will cost $399, while a month's supply of the 5 mg dose will cost $549.